AKI Prevention
On this page
Direct answer
No drug reverses established acute tubular necrosis, which is why prevention is the entire game in acute kidney injury: recognising the at-risk patient — chronic kidney disease, diabetes, age, dehydration, sepsis, contrast, major surgery — and acting before the creatinine moves. The KDIGO definition anchors surveillance: a creatinine rise of 0.3 mg/dL within 48 hours, or 1.5 times baseline within seven days, or urine output below 0.5 mL/kg/h for six hours. Evidence-based prevention is embarrassingly cheap: isotonic crystalloid, nephrotoxin withdrawal including the ACE inhibitor–diuretic–NSAID triple combination, contrast minimisation with saline volume expansion, and early treatment of sepsis. The expensive myths — dopamine, furosemide for protection, N-acetylcysteine — have all been buried by trials.
What you must remember
- Definition: creatinine up 0.3 mg/dL in 48 hours, or 1.5-fold over seven days, or oliguria under 0.5 mL/kg/h for six hours — staging follows severity.
- Risk triad: CKD, diabetes and dehydration interact multiplicatively with sepsis, contrast and aminoglycosides — risk assessment precedes every admission and procedure.
- Fluid choice: isotonic crystalloid, with balanced solutions preferred over large-volume normal saline to limit chloride load; starches are harmful and dextrose is not resuscitation.
- The triple whammy: RAAS blockade plus diuretic plus NSAID — the classic community prescription combination that sends elderly patients into hospital; withholding the offending drugs during illness is prevention.
- Contrast prophylaxis: intravenous isotonic saline and the lowest adequate dose, with 48–72 hours between exposures; the PRESERVE trial showed N-acetylcysteine and bicarbonate add nothing to saline.
- Nephrotoxin and non-drug discipline: extended-interval aminoglycosides with short courses and daily review; low-dose dopamine, fenoldopam and prophylactic furosemide prevent nothing — furosemide may ease volume but changes no outcome.
- Indian aetiology reality: community-acquired AKI in India follows diarrhoeal dehydration, malaria, leptospirosis, dengue, agricultural poisonings and snake bite — Russell's viper envenomation in particular — so prevention includes oral rehydration campaigns, early referral and antivenom access.
- Surveillance and aftercare: cell-cycle arrest markers (TIMP-2 with IGFBP7) and NGAL flag risk hours before creatinine, for triage not diagnosis; KDIGO then mandates three-month reassessment for new chronic kidney disease, since an AKI episode raises long-term kidney risk despite apparent recovery.
A prevention bundle built around one operation
A 61-year-old diabetic with baseline creatinine 1.4 mg/dL is listed for elective cardiac angiography with possible intervention. Day minus seven: the risk audit — his eGFR, his diuretic, his metformin, his NSAID habit bought over the counter; the metformin and the NSAID are stopped, and the plan for withholding his ACE inhibitor the morning of surgery is written down. Day minus one: isotonic saline begins, because volume expansion is the one intervention with trial support. Day zero: the procedure uses the minimum contrast volume in a single sitting, with no second exposure inside 72 hours if it can be helped; N-acetylcysteine is consciously not prescribed, and saying why — PRESERVE — is itself a viva answer. Day one and two: urine output and daily creatinine, with the cell-cycle arrest biomarker used where available to stratify who needs closer observation. Week twelve: the outpatient review that closes the loop — creatinine, blood pressure, albuminuria — because the episode that looked like complete recovery may have quietly started a chronic disease.
How the exam frames it
Three framings recur. The physiology question asks why furosemide fails as protection — converting oliguric to non-oliguric AKI changes the urine output number, not the tubular fate, and may worsen it. The prescribing question hands you a discharge prescription for an elderly diabetic on ramipril, furosemide and diclofenac and asks what happens next; the answer is the triple whammy, and the prevention is the letter that removes the NSAID. The Indian framing is now common in domestic papers: the villager with pain and swelling after a snake bite, or the child with cholera-like diarrhoea — prevention at population level means oral rehydration salts, timely antivenom and referral before the creatinine climbs, a national-programme angle no Western question bank carries.
Frequently asked questions
What defines AKI per KDIGO?
A serum creatinine rise of 0.3 mg/dL within 48 hours, a 1.5-fold rise from baseline within seven days, or urine output below 0.5 mL/kg/h for six hours.
Which fluid prevents AKI best?
Isotonic crystalloid — balanced solutions for large volumes to limit chloride; hydroxyethyl starches are harmful and are avoided.
What is the triple whammy?
Concurrent RAAS blockade, diuretic and NSAID — a combination that precipitates acute kidney injury in older patients, especially during intercurrent illness.
What did the PRESERVE trial show?
Neither intravenous N-acetylcysteine nor sodium bicarbonate outperformed isotonic saline in preventing contrast-associated AKI.
Do biomarkers replace creatinine?
No — TIMP-2•IGFBP7 and NGAL flag risk earlier for triage and monitoring, but management still follows creatinine, urine output and clinical context.
What follow-up follows an AKI episode?
Reassessment around three months for persistent kidney dysfunction and new chronic kidney disease, with blood pressure, creatinine and albuminuria measurement.